PAS
CBIO

Point72 Asia (Singapore)’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Point72 Asia (Singapore)’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-519
Closed -$156K – 1201
2024
Q1 		$156K Buy
+519
New +$156K 0.04% 516